Table 2 of Maier, Mol Vis 2010; 16:53-60.
Study group |
Cytokine (pg/ml) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Il-1b | IL-2 | IL-4 | IL-5 | IL-6 | IL-8 | IL-10* | IL-12 | TNF-α | INF-γ* | ||
Baseline (group 1, n=197) | Mean±SD | 24.94±230.7 | 1.42±0.99 | 1.85±1.15 | 1.13±0.86 | 484.9±1136 | 64.00±180 | 2.17±3.31 | 11.27±75.56 | 0.88±1.32 | 1.49±2.85 |
median | 0 | 1.5 | 1.8 | 1.1 | 18.0 | 10.3 | 1.85 | 1.3 | 0 | 0 | |
(range) | (0–2,943.5) | 0–4.0 | 0–5.7 | 0–3.9 | (0–5,000) | (0–1,148) | (0–29.1) | (0–806.7) | (0–6.7) | 0–11.6 | |
n=0 | 89 | 8 | 5 | 8 | 17 | 12 | 70 | 78 | 125 | 21 | |
n | 163 | 34 | 34 | 34 | 163 | 163 | 197 | 163 | 198 | 34 | |
Acceptors (group 2, n=33) | Mean±SD | 4.53±5.65 | 0.69±1.02 | 1.17±0.99 | 0.81±0.87 | 541.0±1,423 | 24.24±18.84 | 1.92±2.2 | 2.64±2.3 | 0.78±1.36 | 0 |
median | 1.95 | 0 | 1.5 | 1.0 | 49.75 | 18.95 | 1.6 | 2.6 | 0 | 0 | |
(range) | (0–15) | (0–2.6) | (0–2.5) | (0–2.9) | (3.5–5,000) | (5.0–72.9) | (0–7.8) | (0–5.6) | (0–4.8) | na | |
n=0 | 6 | 14 | 8 | 10 | 0 | 0 | 16 | 4 | 23 | 21 | |
n | 12 | 21 | 21 | 21 | 12 | 12 | 33 | 12 | 33 | 21 | |
Rejectors (group 3, n=25) | Mean±SD | 7.86±16.21 | 1.07±1.33 | 1.15±1.28 | 1.37±1.51 | 1,772.4±2.171 | 61.87±53.78 | 5.80±7.11 | 49.54±151 | 1.21±1.88 | 24.09±68.23 |
median | 1.45 | 0 | 1.2 | 1.4 | 385.8 | 47.55 | 3.65 | 2.2 | 0 | 0 | |
(range) | (0–52.7) | 0–3.4 | 0–4.0 | 0–5.90 | (0–5,000) | (4.5–151.2) | (0–32) | (0–479.3) | (0–7.5) | 0–267.9 | |
n=0 | 5 | 8 | 7 | 5 | 1 | 0 | 2 | 4 | 15 | 9 | |
n | 10 | 15 | 15 | 15 | 10 | 10 | 25 | 10 | 25 | 15 |